- Home
- MIRA vs BCHT Comparison
MIRA vs BCHT Comparison
Compare MIRA & BCHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MIRA | BCHT |
|---|---|---|
| Founded | 2020 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.1M | 36.6M |
| IPO Year | 2023 | 2016 |
Fundamental Metrics
Financial Performance| Metric | MIRA | BCHT |
|---|---|---|
| Price | $0.75 | $1.22 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $15.00 |
| AVG Volume (30 Days) | ★ 87.1K | 67.0K |
| Earning Date | 05-13-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $17,626,366.00 |
| Revenue This Year | N/A | $13.42 |
| Revenue Next Year | N/A | $61.22 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 1.26 |
| 52 Week Low | $0.60 | $1.20 |
| 52 Week High | $2.45 | $2.48 |
Technical Indicators
Market Signals| Indicator | MIRA | BCHT |
|---|---|---|
| Relative Strength Index (RSI) | 44.45 | 34.97 |
| Support Level | $0.72 | N/A |
| Resistance Level | $0.83 | $1.54 |
| Average True Range (ATR) | 0.05 | 0.08 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 28.67 | 13.33 |
Price Performance
Historical ComparisonAbout MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a clinical-stage pharmaceutical development company focused on developing novel oral small-molecule therapeutics for neurologic, neuropsychiatric, metabolic, and inflammatory disorders. The company's pipeline includes three product candidates: Ketamir-2, MIRA-55, and SKNY-1, three drug candidates designed to address unmet medical needs across neuropathic and inflammatory pain, central nervous system disorders, and metabolic and behavioral conditions. The company operates as a single operating and reportable segment.
About BCHT Birchtech Corp. Common Stock
Birchtech Corp is a provider of specialty activated carbon technologies, delivering solutions for air and water purification. It provides patented and proprietary Sorbent Enhancement Additive (SEA) technologies for mercury emissions capture to the coal-fired utility sector, and is developing water purification technologies with a specialization on forever chemicals such as PFAS and PFOS. Geographically, the company derives all of its revenue from the United States.